Growing Demand for Vitreous Tamponades Driven by Retinal Diseases and Advanced Surgery Techniques

The market for vitreous tamponades is expected to grow from a valuation of US$78.3 million in 2023 to a valuation of US$105.2 million by 2033. The vitreous tamponades market is the healthcare sector that manufactures and sells products used in ophthalmic surgery to support and stabilise the retina while it heals. Tamponades are frequently used to treat macular holes, retinal detachments, and other retinal conditions.

Vitreous tamponades are typically made of silicone oil or gas and work by temporarily supporting the retina while it heals. They are frequently used in conjunction with other surgical procedures to help restore vision and prevent further damage to the eye, such as vitrectomy (removal of the vitreous gel that fills the eye) and laser therapy. The market for vitreous tamponades is expected to expand further in the coming years, owing to factors such as an ageing population, an increase in the prevalence of retinal diseases, and advances in surgical techniques and materials.

Download Free Sample Copy of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=8082

Key Takeaways from Market Study

  • Global demand for vitreous tamponades is expected to increase at a CAGR of 3% from 2023-2033.
  • China’s market for vitreous tamponades is predicted to expand at a CAGR of 3% during the projected period.
  • Sales of glass tamponades are expected to rise at a CAGR of 3% during the forecast period.
  • Demand for liquid tamponades is predicted to expand at a CAGR of 3% during the next 10 years.

Competitive Landscape

The market is growing steadily, and top players are focusing on creating advanced tamponades in order to increase revenue. For this purpose, they are spending money on research and development. Participants in the market use a variety of strategies, including new product launches, partnerships, collaborations, and more.

  • As an illustration, in 2018 Alcon, Inc. acquired Tear Film Innovations, Inc., a privately held company that made the iLux Device, a therapy tool used to treat Meibomian Gland Dysfunction, a major contributing factor to dry eye.
  • Carl Zeiss Meditec purchased surgical tool manufacturers Kogent Surgical, LLC and Katalyst Surgical, LLC in April 2022 to strengthen its position in the market.

Key Companies Profiled

  • AL.CHI.MI.A. Srl
  • Carl Zeiss Meditec AG
  • Dutch Ophthalmic Research Center International BV (D.O.R.C.)
  • Fluron GmbH
  • Novartis AG
  • Valeant Pharmaceuticals International, Inc.

Regional Analysis Vitreous Tamponades Market

The vitreous tamponades market is a global market, with key players and market demand spread across different regions of the world. The market is expected to show growth in all major regions in the coming years.

North America is expected to hold the largest share of the vitreous tamponades market due to factors such as a large aging population, high prevalence of retinal diseases, and advanced healthcare infrastructure. The presence of major market players such as Novartis AG and Bausch & Lomb Incorporated in the region is also expected to drive market growth.

Europe is also expected to hold a significant share of the market due to the presence of a large number of manufacturers of ophthalmic products, advanced healthcare infrastructure, and increasing investments in R&D.

The Asia Pacific region is expected to show the fastest growth in the market, driven by factors such as a large and rapidly aging population, increasing prevalence of retinal diseases, and improving healthcare infrastructure. In addition, increasing investments in healthcare and rising awareness about the availability of advanced treatment options are expected to further drive market growth in the region.

Related Posts

© 2023 The Tribune City - Theme by WPEnjoy · Powered by WordPress